Calcium, Phosphorus and Magnesium Abnormalities Associated with COVID-19 Infection, and Beyond
- PMID: 37760804
- PMCID: PMC10525362
- DOI: 10.3390/biomedicines11092362
Calcium, Phosphorus and Magnesium Abnormalities Associated with COVID-19 Infection, and Beyond
Abstract
The coronavirus disease (COVID-19) pandemic caused by the novel coronavirus SARS-CoV-2 has had a profound impact on global health, leading to a surge in research to better understand the pathophysiology of the disease. Among the various aspects under investigation, disruptions in mineral homeostasis have emerged as a critical area of interest. This review aims to provide an overview of the current evidence linking calcium, phosphorus and magnesium abnormalities with COVID-19 infection and explores the potential implications beyond the acute phase of the disease. Beyond the acute phase of COVID-19, evidence suggests a potential impact of these mineral abnormalities on long-term health outcomes. Persistent alterations in calcium, phosphorus and magnesium levels have been linked to increased cardiovascular risk, skeletal complications and metabolic disorders, warranting continuous monitoring and management in post-COVID-19 patients.
Keywords: COVID-19; hypocalcemia; hypomagnesemia; hypoparathyroidism; hypophosphatemia; parathyroid hormone; phosphocalcium; post-COVID complications.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous
